Detalles de la búsqueda
1.
Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real-world practice.
Cancer
; 129(4): 590-599, 2023 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36426410
2.
Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-ß/Smad pathway suppression in hepatic stellate cells.
Biochem Biophys Res Commun
; 642: 192-200, 2023 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36586187
3.
Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma.
BMC Gastroenterol
; 23(1): 70, 2023 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36906542
4.
Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice.
BMC Gastroenterol
; 23(1): 101, 2023 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37003980
5.
T1 Mapping Enabled Detection and Follow-up of Rare Immune Checkpoint Inhibitor Myocarditis.
Circ J
; 88(2): 259, 2024 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38123297
6.
Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma.
J Gastroenterol
; 59(6): 515-525, 2024 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38583112
7.
Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury.
Sci Rep
; 13(1): 14043, 2023 08 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37640752
8.
Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients.
Sci Rep
; 13(1): 11524, 2023 07 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37460776
9.
Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis.
Drugs Real World Outcomes
; 10(4): 513-520, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37466822
10.
Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors.
Anticancer Res
; 43(3): 1043-1052, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36854524
11.
Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial.
BMJ Open
; 12(4): e059779, 2022 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35396315
12.
Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience.
J Cancer
; 13(8): 2656-2661, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35711837
Resultados
1 -
12
de 12
1
Próxima >
>>